Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML
Shattuck Labs, Inc.
Shattuck Labs, Inc.
National Cancer Institute (NCI)
Emory University
National Cancer Institute (NCI)
NextCure, Inc.
Kahr Medical
Bristol-Myers Squibb
Amgen
Celgene
University of Michigan Rogel Cancer Center
Cyclacel Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc.
Amgen
Inmune Bio, Inc.
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
OHSU Knight Cancer Institute
AbbVie
Hemavant Sciences GmbH
Prelude Therapeutics
Amgen
Baylor College of Medicine
Indiana University
Bayer
Medical College of Wisconsin
Gilead Sciences
Barbara Ann Karmanos Cancer Institute
University of Pennsylvania
Jonsson Comprehensive Cancer Center
University of Florida
Dana-Farber Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Plexxikon
St. Jude Children's Research Hospital
Celgene
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
University of Florida
Alliance for Clinical Trials in Oncology
Erimos Pharmaceuticals
Indiana University
Celgene
Merck Sharp & Dohme LLC
New York Medical College
Technische Universität Dresden
Duke University